0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Peripheral Drug-Coated Balloon Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-20J12943
Home | Market Reports | Health| Medical Devices & Equipment
Global Peripheral Drug Coated Balloon Industry Research Report Growth Trends and Competitive Analysis 2022 2028
BUY CHAPTERS

Global Peripheral Drug-Coated Balloon Market Research Report 2025

Code: QYRE-Auto-20J12943
Report
July 2025
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Peripheral Drug-Coated Balloon Market Size

The global market for Peripheral Drug-Coated Balloon was valued at US$ 975 million in the year 2024 and is projected to reach a revised size of US$ 1536 million by 2031, growing at a CAGR of 6.8% during the forecast period.

Peripheral Drug-Coated Balloon Market

Peripheral Drug-Coated Balloon Market

Drug-coated balloons (DCB) have been introduced to improve patency rates following endovascular intervention for lower extremity PAD. They have gained popularity among endovascular specialists due to its ease of use and the concept of “leave nothing behind”.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Peripheral Drug-Coated Balloon, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peripheral Drug-Coated Balloon.
The Peripheral Drug-Coated Balloon market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peripheral Drug-Coated Balloon market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peripheral Drug-Coated Balloon manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Peripheral Drug-Coated Balloon Market Report

Report Metric Details
Report Name Peripheral Drug-Coated Balloon Market
Accounted market size in year US$ 975 million
Forecasted market size in 2031 US$ 1536 million
CAGR 6.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Paclitaxel
  • Sirolimus
  • Others
Segment by Application
  • Hospital
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Cordis, Defibtech, Abbott Laboratories, REVA Medical, Shimadzu, Opto Circuits, Biotronik, Endologix, SMT, Philips Healthcare, Elixir Medical, CorMatrix Cardiovascular, Advanced Cardiac Therapeutics, Edwards Lifesciences, Impulse Dynamics, Stereotaxis
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Peripheral Drug-Coated Balloon manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Peripheral Drug-Coated Balloon in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Peripheral Drug-Coated Balloon Market growing?

Ans: The Peripheral Drug-Coated Balloon Market witnessing a CAGR of 6.8% during the forecast period 2025-2031.

What is the Peripheral Drug-Coated Balloon Market size in 2031?

Ans: The Peripheral Drug-Coated Balloon Market size in 2031 will be US$ 1536 million.

Who are the main players in the Peripheral Drug-Coated Balloon Market report?

Ans: The main players in the Peripheral Drug-Coated Balloon Market are Cordis, Defibtech, Abbott Laboratories, REVA Medical, Shimadzu, Opto Circuits, Biotronik, Endologix, SMT, Philips Healthcare, Elixir Medical, CorMatrix Cardiovascular, Advanced Cardiac Therapeutics, Edwards Lifesciences, Impulse Dynamics, Stereotaxis

What are the Application segmentation covered in the Peripheral Drug-Coated Balloon Market report?

Ans: The Applications covered in the Peripheral Drug-Coated Balloon Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Peripheral Drug-Coated Balloon Market report?

Ans: The Types covered in the Peripheral Drug-Coated Balloon Market report are Paclitaxel, Sirolimus, Others

1 Peripheral Drug-Coated Balloon Market Overview
1.1 Product Definition
1.2 Peripheral Drug-Coated Balloon by Type
1.2.1 Global Peripheral Drug-Coated Balloon Market Value Comparison by Type (2024 VS 2031)
1.2.2 Paclitaxel
1.2.3 Sirolimus
1.2.4 Others
1.3 Peripheral Drug-Coated Balloon by Application
1.3.1 Global Peripheral Drug-Coated Balloon Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Peripheral Drug-Coated Balloon Market Size Estimates and Forecasts
1.4.1 Global Peripheral Drug-Coated Balloon Revenue 2020-2031
1.4.2 Global Peripheral Drug-Coated Balloon Sales 2020-2031
1.4.3 Global Peripheral Drug-Coated Balloon Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Peripheral Drug-Coated Balloon Market Competition by Manufacturers
2.1 Global Peripheral Drug-Coated Balloon Sales Market Share by Manufacturers (2020-2025)
2.2 Global Peripheral Drug-Coated Balloon Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Peripheral Drug-Coated Balloon Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Peripheral Drug-Coated Balloon, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Peripheral Drug-Coated Balloon, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Peripheral Drug-Coated Balloon, Product Type & Application
2.7 Global Key Manufacturers of Peripheral Drug-Coated Balloon, Date of Enter into This Industry
2.8 Global Peripheral Drug-Coated Balloon Market Competitive Situation and Trends
2.8.1 Global Peripheral Drug-Coated Balloon Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Peripheral Drug-Coated Balloon Players Market Share by Revenue
2.8.3 Global Peripheral Drug-Coated Balloon Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Peripheral Drug-Coated Balloon Market Scenario by Region
3.1 Global Peripheral Drug-Coated Balloon Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Peripheral Drug-Coated Balloon Sales by Region: 2020-2031
3.2.1 Global Peripheral Drug-Coated Balloon Sales by Region: 2020-2025
3.2.2 Global Peripheral Drug-Coated Balloon Sales by Region: 2026-2031
3.3 Global Peripheral Drug-Coated Balloon Revenue by Region: 2020-2031
3.3.1 Global Peripheral Drug-Coated Balloon Revenue by Region: 2020-2025
3.3.2 Global Peripheral Drug-Coated Balloon Revenue by Region: 2026-2031
3.4 North America Peripheral Drug-Coated Balloon Market Facts & Figures by Country
3.4.1 North America Peripheral Drug-Coated Balloon Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Peripheral Drug-Coated Balloon Sales by Country (2020-2031)
3.4.3 North America Peripheral Drug-Coated Balloon Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Peripheral Drug-Coated Balloon Market Facts & Figures by Country
3.5.1 Europe Peripheral Drug-Coated Balloon Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Peripheral Drug-Coated Balloon Sales by Country (2020-2031)
3.5.3 Europe Peripheral Drug-Coated Balloon Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Peripheral Drug-Coated Balloon Market Facts & Figures by Region
3.6.1 Asia Pacific Peripheral Drug-Coated Balloon Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Peripheral Drug-Coated Balloon Sales by Region (2020-2031)
3.6.3 Asia Pacific Peripheral Drug-Coated Balloon Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Peripheral Drug-Coated Balloon Market Facts & Figures by Country
3.7.1 Latin America Peripheral Drug-Coated Balloon Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Peripheral Drug-Coated Balloon Sales by Country (2020-2031)
3.7.3 Latin America Peripheral Drug-Coated Balloon Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Peripheral Drug-Coated Balloon Market Facts & Figures by Country
3.8.1 Middle East and Africa Peripheral Drug-Coated Balloon Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Peripheral Drug-Coated Balloon Sales by Country (2020-2031)
3.8.3 Middle East and Africa Peripheral Drug-Coated Balloon Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Peripheral Drug-Coated Balloon Sales by Type (2020-2031)
4.1.1 Global Peripheral Drug-Coated Balloon Sales by Type (2020-2025)
4.1.2 Global Peripheral Drug-Coated Balloon Sales by Type (2026-2031)
4.1.3 Global Peripheral Drug-Coated Balloon Sales Market Share by Type (2020-2031)
4.2 Global Peripheral Drug-Coated Balloon Revenue by Type (2020-2031)
4.2.1 Global Peripheral Drug-Coated Balloon Revenue by Type (2020-2025)
4.2.2 Global Peripheral Drug-Coated Balloon Revenue by Type (2026-2031)
4.2.3 Global Peripheral Drug-Coated Balloon Revenue Market Share by Type (2020-2031)
4.3 Global Peripheral Drug-Coated Balloon Price by Type (2020-2031)
5 Segment by Application
5.1 Global Peripheral Drug-Coated Balloon Sales by Application (2020-2031)
5.1.1 Global Peripheral Drug-Coated Balloon Sales by Application (2020-2025)
5.1.2 Global Peripheral Drug-Coated Balloon Sales by Application (2026-2031)
5.1.3 Global Peripheral Drug-Coated Balloon Sales Market Share by Application (2020-2031)
5.2 Global Peripheral Drug-Coated Balloon Revenue by Application (2020-2031)
5.2.1 Global Peripheral Drug-Coated Balloon Revenue by Application (2020-2025)
5.2.2 Global Peripheral Drug-Coated Balloon Revenue by Application (2026-2031)
5.2.3 Global Peripheral Drug-Coated Balloon Revenue Market Share by Application (2020-2031)
5.3 Global Peripheral Drug-Coated Balloon Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Cordis
6.1.1 Cordis Company Information
6.1.2 Cordis Description and Business Overview
6.1.3 Cordis Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Cordis Peripheral Drug-Coated Balloon Product Portfolio
6.1.5 Cordis Recent Developments/Updates
6.2 Defibtech
6.2.1 Defibtech Company Information
6.2.2 Defibtech Description and Business Overview
6.2.3 Defibtech Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Defibtech Peripheral Drug-Coated Balloon Product Portfolio
6.2.5 Defibtech Recent Developments/Updates
6.3 Abbott Laboratories
6.3.1 Abbott Laboratories Company Information
6.3.2 Abbott Laboratories Description and Business Overview
6.3.3 Abbott Laboratories Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Abbott Laboratories Peripheral Drug-Coated Balloon Product Portfolio
6.3.5 Abbott Laboratories Recent Developments/Updates
6.4 REVA Medical
6.4.1 REVA Medical Company Information
6.4.2 REVA Medical Description and Business Overview
6.4.3 REVA Medical Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2020-2025)
6.4.4 REVA Medical Peripheral Drug-Coated Balloon Product Portfolio
6.4.5 REVA Medical Recent Developments/Updates
6.5 Shimadzu
6.5.1 Shimadzu Company Information
6.5.2 Shimadzu Description and Business Overview
6.5.3 Shimadzu Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Shimadzu Peripheral Drug-Coated Balloon Product Portfolio
6.5.5 Shimadzu Recent Developments/Updates
6.6 Opto Circuits
6.6.1 Opto Circuits Company Information
6.6.2 Opto Circuits Description and Business Overview
6.6.3 Opto Circuits Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Opto Circuits Peripheral Drug-Coated Balloon Product Portfolio
6.6.5 Opto Circuits Recent Developments/Updates
6.7 Biotronik
6.7.1 Biotronik Company Information
6.7.2 Biotronik Description and Business Overview
6.7.3 Biotronik Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Biotronik Peripheral Drug-Coated Balloon Product Portfolio
6.7.5 Biotronik Recent Developments/Updates
6.8 Endologix
6.8.1 Endologix Company Information
6.8.2 Endologix Description and Business Overview
6.8.3 Endologix Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Endologix Peripheral Drug-Coated Balloon Product Portfolio
6.8.5 Endologix Recent Developments/Updates
6.9 SMT
6.9.1 SMT Company Information
6.9.2 SMT Description and Business Overview
6.9.3 SMT Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2020-2025)
6.9.4 SMT Peripheral Drug-Coated Balloon Product Portfolio
6.9.5 SMT Recent Developments/Updates
6.10 Philips Healthcare
6.10.1 Philips Healthcare Company Information
6.10.2 Philips Healthcare Description and Business Overview
6.10.3 Philips Healthcare Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Philips Healthcare Peripheral Drug-Coated Balloon Product Portfolio
6.10.5 Philips Healthcare Recent Developments/Updates
6.11 Elixir Medical
6.11.1 Elixir Medical Company Information
6.11.2 Elixir Medical Description and Business Overview
6.11.3 Elixir Medical Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Elixir Medical Peripheral Drug-Coated Balloon Product Portfolio
6.11.5 Elixir Medical Recent Developments/Updates
6.12 CorMatrix Cardiovascular
6.12.1 CorMatrix Cardiovascular Company Information
6.12.2 CorMatrix Cardiovascular Description and Business Overview
6.12.3 CorMatrix Cardiovascular Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2020-2025)
6.12.4 CorMatrix Cardiovascular Peripheral Drug-Coated Balloon Product Portfolio
6.12.5 CorMatrix Cardiovascular Recent Developments/Updates
6.13 Advanced Cardiac Therapeutics
6.13.1 Advanced Cardiac Therapeutics Company Information
6.13.2 Advanced Cardiac Therapeutics Description and Business Overview
6.13.3 Advanced Cardiac Therapeutics Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Advanced Cardiac Therapeutics Peripheral Drug-Coated Balloon Product Portfolio
6.13.5 Advanced Cardiac Therapeutics Recent Developments/Updates
6.14 Edwards Lifesciences
6.14.1 Edwards Lifesciences Company Information
6.14.2 Edwards Lifesciences Description and Business Overview
6.14.3 Edwards Lifesciences Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Edwards Lifesciences Peripheral Drug-Coated Balloon Product Portfolio
6.14.5 Edwards Lifesciences Recent Developments/Updates
6.15 Impulse Dynamics
6.15.1 Impulse Dynamics Company Information
6.15.2 Impulse Dynamics Description and Business Overview
6.15.3 Impulse Dynamics Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Impulse Dynamics Peripheral Drug-Coated Balloon Product Portfolio
6.15.5 Impulse Dynamics Recent Developments/Updates
6.16 Stereotaxis
6.16.1 Stereotaxis Company Information
6.16.2 Stereotaxis Description and Business Overview
6.16.3 Stereotaxis Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Stereotaxis Peripheral Drug-Coated Balloon Product Portfolio
6.16.5 Stereotaxis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Peripheral Drug-Coated Balloon Industry Chain Analysis
7.2 Peripheral Drug-Coated Balloon Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Peripheral Drug-Coated Balloon Production Mode & Process Analysis
7.4 Peripheral Drug-Coated Balloon Sales and Marketing
7.4.1 Peripheral Drug-Coated Balloon Sales Channels
7.4.2 Peripheral Drug-Coated Balloon Distributors
7.5 Peripheral Drug-Coated Balloon Customer Analysis
8 Peripheral Drug-Coated Balloon Market Dynamics
8.1 Peripheral Drug-Coated Balloon Industry Trends
8.2 Peripheral Drug-Coated Balloon Market Drivers
8.3 Peripheral Drug-Coated Balloon Market Challenges
8.4 Peripheral Drug-Coated Balloon Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Peripheral Drug-Coated Balloon Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Peripheral Drug-Coated Balloon Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Peripheral Drug-Coated Balloon Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Peripheral Drug-Coated Balloon Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Peripheral Drug-Coated Balloon Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Peripheral Drug-Coated Balloon Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Peripheral Drug-Coated Balloon Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Peripheral Drug-Coated Balloon Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Peripheral Drug-Coated Balloon, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Peripheral Drug-Coated Balloon, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Peripheral Drug-Coated Balloon, Product Type & Application
 Table 12. Global Key Manufacturers of Peripheral Drug-Coated Balloon, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Peripheral Drug-Coated Balloon by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Drug-Coated Balloon as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Peripheral Drug-Coated Balloon Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Peripheral Drug-Coated Balloon Sales by Region (2020-2025) & (K Units)
 Table 18. Global Peripheral Drug-Coated Balloon Sales Market Share by Region (2020-2025)
 Table 19. Global Peripheral Drug-Coated Balloon Sales by Region (2026-2031) & (K Units)
 Table 20. Global Peripheral Drug-Coated Balloon Sales Market Share by Region (2026-2031)
 Table 21. Global Peripheral Drug-Coated Balloon Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Peripheral Drug-Coated Balloon Revenue Market Share by Region (2020-2025)
 Table 23. Global Peripheral Drug-Coated Balloon Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Peripheral Drug-Coated Balloon Revenue Market Share by Region (2026-2031)
 Table 25. North America Peripheral Drug-Coated Balloon Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Peripheral Drug-Coated Balloon Sales by Country (2020-2025) & (K Units)
 Table 27. North America Peripheral Drug-Coated Balloon Sales by Country (2026-2031) & (K Units)
 Table 28. North America Peripheral Drug-Coated Balloon Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Peripheral Drug-Coated Balloon Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Peripheral Drug-Coated Balloon Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Peripheral Drug-Coated Balloon Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Peripheral Drug-Coated Balloon Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Peripheral Drug-Coated Balloon Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Peripheral Drug-Coated Balloon Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Peripheral Drug-Coated Balloon Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Peripheral Drug-Coated Balloon Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Peripheral Drug-Coated Balloon Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Peripheral Drug-Coated Balloon Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Peripheral Drug-Coated Balloon Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Peripheral Drug-Coated Balloon Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Peripheral Drug-Coated Balloon Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Peripheral Drug-Coated Balloon Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Peripheral Drug-Coated Balloon Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Peripheral Drug-Coated Balloon Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Peripheral Drug-Coated Balloon Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Peripheral Drug-Coated Balloon Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Peripheral Drug-Coated Balloon Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Peripheral Drug-Coated Balloon Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Peripheral Drug-Coated Balloon Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Peripheral Drug-Coated Balloon Sales (K Units) by Type (2020-2025)
 Table 51. Global Peripheral Drug-Coated Balloon Sales (K Units) by Type (2026-2031)
 Table 52. Global Peripheral Drug-Coated Balloon Sales Market Share by Type (2020-2025)
 Table 53. Global Peripheral Drug-Coated Balloon Sales Market Share by Type (2026-2031)
 Table 54. Global Peripheral Drug-Coated Balloon Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Peripheral Drug-Coated Balloon Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Peripheral Drug-Coated Balloon Revenue Market Share by Type (2020-2025)
 Table 57. Global Peripheral Drug-Coated Balloon Revenue Market Share by Type (2026-2031)
 Table 58. Global Peripheral Drug-Coated Balloon Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Peripheral Drug-Coated Balloon Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Peripheral Drug-Coated Balloon Sales (K Units) by Application (2020-2025)
 Table 61. Global Peripheral Drug-Coated Balloon Sales (K Units) by Application (2026-2031)
 Table 62. Global Peripheral Drug-Coated Balloon Sales Market Share by Application (2020-2025)
 Table 63. Global Peripheral Drug-Coated Balloon Sales Market Share by Application (2026-2031)
 Table 64. Global Peripheral Drug-Coated Balloon Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Peripheral Drug-Coated Balloon Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Peripheral Drug-Coated Balloon Revenue Market Share by Application (2020-2025)
 Table 67. Global Peripheral Drug-Coated Balloon Revenue Market Share by Application (2026-2031)
 Table 68. Global Peripheral Drug-Coated Balloon Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Peripheral Drug-Coated Balloon Price (US$/Unit) by Application (2026-2031)
 Table 70. Cordis Company Information
 Table 71. Cordis Description and Business Overview
 Table 72. Cordis Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Cordis Peripheral Drug-Coated Balloon Product
 Table 74. Cordis Recent Developments/Updates
 Table 75. Defibtech Company Information
 Table 76. Defibtech Description and Business Overview
 Table 77. Defibtech Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Defibtech Peripheral Drug-Coated Balloon Product
 Table 79. Defibtech Recent Developments/Updates
 Table 80. Abbott Laboratories Company Information
 Table 81. Abbott Laboratories Description and Business Overview
 Table 82. Abbott Laboratories Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Abbott Laboratories Peripheral Drug-Coated Balloon Product
 Table 84. Abbott Laboratories Recent Developments/Updates
 Table 85. REVA Medical Company Information
 Table 86. REVA Medical Description and Business Overview
 Table 87. REVA Medical Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. REVA Medical Peripheral Drug-Coated Balloon Product
 Table 89. REVA Medical Recent Developments/Updates
 Table 90. Shimadzu Company Information
 Table 91. Shimadzu Description and Business Overview
 Table 92. Shimadzu Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Shimadzu Peripheral Drug-Coated Balloon Product
 Table 94. Shimadzu Recent Developments/Updates
 Table 95. Opto Circuits Company Information
 Table 96. Opto Circuits Description and Business Overview
 Table 97. Opto Circuits Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Opto Circuits Peripheral Drug-Coated Balloon Product
 Table 99. Opto Circuits Recent Developments/Updates
 Table 100. Biotronik Company Information
 Table 101. Biotronik Description and Business Overview
 Table 102. Biotronik Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Biotronik Peripheral Drug-Coated Balloon Product
 Table 104. Biotronik Recent Developments/Updates
 Table 105. Endologix Company Information
 Table 106. Endologix Description and Business Overview
 Table 107. Endologix Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Endologix Peripheral Drug-Coated Balloon Product
 Table 109. Endologix Recent Developments/Updates
 Table 110. SMT Company Information
 Table 111. SMT Description and Business Overview
 Table 112. SMT Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. SMT Peripheral Drug-Coated Balloon Product
 Table 114. SMT Recent Developments/Updates
 Table 115. Philips Healthcare Company Information
 Table 116. Philips Healthcare Description and Business Overview
 Table 117. Philips Healthcare Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Philips Healthcare Peripheral Drug-Coated Balloon Product
 Table 119. Philips Healthcare Recent Developments/Updates
 Table 120. Elixir Medical Company Information
 Table 121. Elixir Medical Description and Business Overview
 Table 122. Elixir Medical Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Elixir Medical Peripheral Drug-Coated Balloon Product
 Table 124. Elixir Medical Recent Developments/Updates
 Table 125. CorMatrix Cardiovascular Company Information
 Table 126. CorMatrix Cardiovascular Description and Business Overview
 Table 127. CorMatrix Cardiovascular Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. CorMatrix Cardiovascular Peripheral Drug-Coated Balloon Product
 Table 129. CorMatrix Cardiovascular Recent Developments/Updates
 Table 130. Advanced Cardiac Therapeutics Company Information
 Table 131. Advanced Cardiac Therapeutics Description and Business Overview
 Table 132. Advanced Cardiac Therapeutics Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Advanced Cardiac Therapeutics Peripheral Drug-Coated Balloon Product
 Table 134. Advanced Cardiac Therapeutics Recent Developments/Updates
 Table 135. Edwards Lifesciences Company Information
 Table 136. Edwards Lifesciences Description and Business Overview
 Table 137. Edwards Lifesciences Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Edwards Lifesciences Peripheral Drug-Coated Balloon Product
 Table 139. Edwards Lifesciences Recent Developments/Updates
 Table 140. Impulse Dynamics Company Information
 Table 141. Impulse Dynamics Description and Business Overview
 Table 142. Impulse Dynamics Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Impulse Dynamics Peripheral Drug-Coated Balloon Product
 Table 144. Impulse Dynamics Recent Developments/Updates
 Table 145. Stereotaxis Company Information
 Table 146. Stereotaxis Description and Business Overview
 Table 147. Stereotaxis Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Stereotaxis Peripheral Drug-Coated Balloon Product
 Table 149. Stereotaxis Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Peripheral Drug-Coated Balloon Distributors List
 Table 153. Peripheral Drug-Coated Balloon Customers List
 Table 154. Peripheral Drug-Coated Balloon Market Trends
 Table 155. Peripheral Drug-Coated Balloon Market Drivers
 Table 156. Peripheral Drug-Coated Balloon Market Challenges
 Table 157. Peripheral Drug-Coated Balloon Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Peripheral Drug-Coated Balloon
 Figure 2. Global Peripheral Drug-Coated Balloon Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Peripheral Drug-Coated Balloon Market Share by Type: 2024 & 2031
 Figure 4. Paclitaxel Product Picture
 Figure 5. Sirolimus Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Peripheral Drug-Coated Balloon Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Peripheral Drug-Coated Balloon Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Clinic
 Figure 11. Others
 Figure 12. Global Peripheral Drug-Coated Balloon Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Peripheral Drug-Coated Balloon Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Peripheral Drug-Coated Balloon Sales (2020-2031) & (K Units)
 Figure 15. Global Peripheral Drug-Coated Balloon Average Price (US$/Unit) & (2020-2031)
 Figure 16. Peripheral Drug-Coated Balloon Report Years Considered
 Figure 17. Peripheral Drug-Coated Balloon Sales Share by Manufacturers in 2024
 Figure 18. Global Peripheral Drug-Coated Balloon Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Peripheral Drug-Coated Balloon Players: Market Share by Revenue in Peripheral Drug-Coated Balloon in 2024
 Figure 20. Peripheral Drug-Coated Balloon Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Peripheral Drug-Coated Balloon Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Peripheral Drug-Coated Balloon Sales Market Share by Country (2020-2031)
 Figure 23. North America Peripheral Drug-Coated Balloon Revenue Market Share by Country (2020-2031)
 Figure 24. United States Peripheral Drug-Coated Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Peripheral Drug-Coated Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Peripheral Drug-Coated Balloon Sales Market Share by Country (2020-2031)
 Figure 27. Europe Peripheral Drug-Coated Balloon Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Peripheral Drug-Coated Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Peripheral Drug-Coated Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Peripheral Drug-Coated Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Peripheral Drug-Coated Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Peripheral Drug-Coated Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Peripheral Drug-Coated Balloon Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Peripheral Drug-Coated Balloon Revenue Market Share by Region (2020-2031)
 Figure 35. China Peripheral Drug-Coated Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Peripheral Drug-Coated Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Peripheral Drug-Coated Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Peripheral Drug-Coated Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Peripheral Drug-Coated Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Peripheral Drug-Coated Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Peripheral Drug-Coated Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Peripheral Drug-Coated Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Peripheral Drug-Coated Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Peripheral Drug-Coated Balloon Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Peripheral Drug-Coated Balloon Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Peripheral Drug-Coated Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Peripheral Drug-Coated Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Peripheral Drug-Coated Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Colombia Peripheral Drug-Coated Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Peripheral Drug-Coated Balloon Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Peripheral Drug-Coated Balloon Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Peripheral Drug-Coated Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Peripheral Drug-Coated Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Peripheral Drug-Coated Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Peripheral Drug-Coated Balloon by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Peripheral Drug-Coated Balloon by Type (2020-2031)
 Figure 57. Global Peripheral Drug-Coated Balloon Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Peripheral Drug-Coated Balloon by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Peripheral Drug-Coated Balloon by Application (2020-2031)
 Figure 60. Global Peripheral Drug-Coated Balloon Price (US$/Unit) by Application (2020-2031)
 Figure 61. Peripheral Drug-Coated Balloon Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart